+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
AI Medical Imaging Software for Cerebrovascular Diseases Market - Global Forecast 2026-2032- Product Image
AI Medical Imaging Software for Cerebrovascular Diseases Market - Global Forecast 2026-2032- Product Image
New

AI Medical Imaging Software for Cerebrovascular Diseases Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 188 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6127418
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

AI medical imaging software is fundamentally transforming cerebrovascular disease management by accelerating and standardizing stroke diagnosis within complex hospital settings. Senior decision-makers are increasingly turning to platforms that support scalable care coordination, deliver operational value, and align with evolving clinical workflows.

Market Snapshot: AI Medical Imaging Software for Cerebrovascular Diseases

The global market for AI medical imaging software targeting cerebrovascular applications is growing rapidly, marked by robust adoption in acute care and post-acute monitoring workflows. Market acceleration is propelled by demand for technologies that reduce diagnostic timelines, improve detection specificity, and support triage across a variety of stroke and vascular presentations. These solutions are becoming central to both large health systems and community networks that require consistent, high-quality diagnostics and optimized multidisciplinary care pathways. The sector’s growth trajectory reflects ongoing healthcare digitization, expansion of remote care models, and the rising prominence of AI-driven clinical informatics within neurological care delivery environments.

Scope & Segmentation

This report offers comprehensive analysis of the AI medical imaging software market for cerebrovascular diseases, providing actionable intelligence for different organizational contexts. Technologies, workflows, buyer needs, and deployment models are benchmarked by region and care setting.

  • Imaging Modalities: AI solutions address diverse requirements through CT, CTA, CTP, and MRI, supporting both routine and advanced neuroimaging scenarios.
  • Application Areas: Key functionalities span hemorrhage detection, large vessel occlusion triage, perfusion analytics, and longitudinal monitoring for tracking vascular outcomes.
  • Deployment Architectures: Organizations can deploy cloud-based, on-premises, or hybrid systems, balancing security needs with operational flexibility and data controls.
  • Workflow Integration: Solutions include PACS/RIS-embedded modules, standalone viewers, and tools to enhance communication and collaboration across departments such as radiology, neurology, and emergency care.
  • End-User Segments: Leading adoption is seen in comprehensive stroke centers, regional hospital networks, primary stroke hubs, community facilities, and specialized imaging providers.
  • Geographic Regions: Market insights are benchmarked for North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa, taking into consideration varying levels of digital infrastructure and regulatory readiness.

Key Takeaways

  • Vendors are shifting focus from single-algorithm tools to integrated neurovascular AI platforms, simplifying implementation and staff training across multidisciplinary teams.
  • Operational decision-making now heavily weighs workflow-first deployment and multimodal imaging compatibility as much as model accuracy, influencing enterprise procurement strategies.
  • Hospitals require not only seamless PACS/RIS integration but also assurances around security, clinical governance, and mechanisms for ongoing performance monitoring post-deployment.
  • Purchasing evaluations emphasize solutions that demonstrate tangible real-world impact, such as reduced diagnostic delays, greater care consistency, and actionable data for next-step interventions.
  • Adoption trends reveal strong uptake among advanced stroke centers and growing penetration across community and regional hospitals, with deployment success often tied to workflow ownership and operational alignment.
  • Differentiation is increasingly linked to user experience, sound data governance, and the ability to validate clinical improvements across diverse technical infrastructures and provider settings.

Tariff Impact: Navigating U.S. Hardware and Infrastructure Volatility

Recent United States tariff measures are having a significant impact on procurement strategies for AI imaging software. Cost increases for essential hardware components such as GPUs and servers are compelling healthcare organizations to reconsider capital expenditures and pace their technology adoption. Fluctuations in cloud pricing are driving buyers to evaluate the compute efficiency and scalability of proposed solutions, as well as to seek transparent supply chain practices from vendors. These dynamics are prompting procurement teams to favor platforms that offer deployment flexibility and reduced vulnerability to market disruptions, ensuring continuity in both hardware-dependent and cloud-based architectures.

AI Medical Imaging Software in Clinical Decision Support

AI medical imaging software is now integral to clinical decision support, particularly for stroke teams managing rapid, high-stakes cases. By harmonizing neurology, radiology, and emergency workflows, these platforms help deliver timely, defensible, and standardized care across institutional settings with varying resources.

Methodology & Data Sources

The findings in this report are based on structured interviews with key stakeholders, including radiologists, neurologists, imaging administrators, IT leaders, procurement officers, and AI solution vendors. This primary research is augmented by review of regulatory clearances, clinical trial literature, and published vendor documentation to ensure accuracy and operational relevancy.

Why This Report Matters

  • Delivers pragmatic insights for senior leadership on adopting and integrating AI medical imaging within complex stroke care environments.
  • Provides comparative benchmarks for leading vendors, preferred deployment strategies, and governance practices to guide evidence-based decision-making.
  • Presents actionable, region-specific intelligence to support risk management, cost control, and workflow optimization for health systems seeking to scale AI-driven solutions.

Conclusion

AI medical imaging software gives senior healthcare leaders an opportunity to align investment decisions with their organizational goals for operational scalability and improved patient outcomes. Effective adoption requires solutions grounded in workflow integration, robust security, and disciplined governance frameworks.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. AI Medical Imaging Software for Cerebrovascular Diseases Market, by Component
8.1. Services
8.1.1. Consulting
8.1.2. Maintenance
8.1.3. Training Support
8.2. Software
9. AI Medical Imaging Software for Cerebrovascular Diseases Market, by Modality
9.1. Ct
9.2. Mri
9.3. Pet
9.4. Ultrasound
10. AI Medical Imaging Software for Cerebrovascular Diseases Market, by Deployment
10.1. Cloud
10.2. On Premise
11. AI Medical Imaging Software for Cerebrovascular Diseases Market, by Algorithm
11.1. Deep Learning
11.2. Machine Learning
12. AI Medical Imaging Software for Cerebrovascular Diseases Market, by Application
12.1. Aneurysm Detection
12.2. Hemorrhage Analysis
12.3. Perfusion Analysis
12.4. Stroke Detection
13. AI Medical Imaging Software for Cerebrovascular Diseases Market, by End User
13.1. Ambulatory Care
13.2. Diagnostic Centers
13.3. Hospitals
13.4. Research Institutes
14. AI Medical Imaging Software for Cerebrovascular Diseases Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. AI Medical Imaging Software for Cerebrovascular Diseases Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. AI Medical Imaging Software for Cerebrovascular Diseases Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States AI Medical Imaging Software for Cerebrovascular Diseases Market
18. China AI Medical Imaging Software for Cerebrovascular Diseases Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Aidoc Medical Ltd
19.6. Arterys, Inc.
19.7. Brainomix Ltd
19.8. Cercare Medical, Inc.
19.9. Enlitic, Inc.
19.10. GE HealthCare Technologies, Inc.
19.11. icometrix NV
19.12. iSchemaView, Inc.
19.13. Koninklijke Philips N.V.
19.14. Lunit Inc.
19.15. Medtronic plc
19.16. Quibim S.L.
19.17. Qure.ai Technologies Pvt. Ltd
19.18. RapidAI, Inc.
19.19. Siemens Healthineers AG
19.20. Subtle Medical, Inc.
19.21. Viz.ai, Inc.
19.22. Zebra Medical Vision Ltd
List of Figures
FIGURE 1. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DEPLOYMENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ALGORITHM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY CONSULTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY CONSULTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY CONSULTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY TRAINING SUPPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY TRAINING SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY TRAINING SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY CT, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY CT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY CT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MRI, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MRI, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MRI, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY PET, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY PET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY PET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY CLOUD, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY CLOUD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ALGORITHM, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DEEP LEARNING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DEEP LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MACHINE LEARNING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MACHINE LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ANEURYSM DETECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ANEURYSM DETECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ANEURYSM DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY HEMORRHAGE ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY HEMORRHAGE ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY HEMORRHAGE ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY PERFUSION ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY PERFUSION ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY PERFUSION ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY STROKE DETECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY STROKE DETECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY STROKE DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ALGORITHM, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ALGORITHM, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ALGORITHM, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ALGORITHM, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 105. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 107. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 108. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 109. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 110. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ALGORITHM, 2018-2032 (USD MILLION)
TABLE 111. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 112. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ALGORITHM, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 121. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 123. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 124. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 125. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 126. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ALGORITHM, 2018-2032 (USD MILLION)
TABLE 127. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 128. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ALGORITHM, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 140. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 141. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 142. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 143. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ALGORITHM, 2018-2032 (USD MILLION)
TABLE 144. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 145. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. GCC AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GCC AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 148. GCC AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 149. GCC AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 150. GCC AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 151. GCC AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ALGORITHM, 2018-2032 (USD MILLION)
TABLE 152. GCC AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. GCC AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ALGORITHM, 2018-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 162. BRICS AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. BRICS AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 164. BRICS AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 165. BRICS AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 166. BRICS AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 167. BRICS AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ALGORITHM, 2018-2032 (USD MILLION)
TABLE 168. BRICS AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 169. BRICS AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. G7 AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. G7 AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 172. G7 AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 173. G7 AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 174. G7 AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 175. G7 AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ALGORITHM, 2018-2032 (USD MILLION)
TABLE 176. G7 AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 177. G7 AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 178. NATO AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. NATO AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 180. NATO AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 181. NATO AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 182. NATO AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 183. NATO AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ALGORITHM, 2018-2032 (USD MILLION)
TABLE 184. NATO AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 185. NATO AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 188. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 189. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 190. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 191. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 192. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ALGORITHM, 2018-2032 (USD MILLION)
TABLE 193. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 194. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 195. CHINA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 196. CHINA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 197. CHINA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 198. CHINA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 199. CHINA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
TABLE 200. CHINA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY ALGORITHM, 2018-2032 (USD MILLION)
TABLE 201. CHINA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 202. CHINA AI MEDICAL IMAGING SOFTWARE FOR CEREBROVASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this AI Medical Imaging Software for Cerebrovascular Diseases market report include:
  • Aidoc Medical Ltd
  • Arterys, Inc.
  • Brainomix Ltd
  • Cercare Medical, Inc.
  • Enlitic, Inc.
  • GE HealthCare Technologies, Inc.
  • icometrix NV
  • iSchemaView, Inc.
  • Koninklijke Philips N.V.
  • Lunit Inc.
  • Medtronic plc
  • Quibim S.L.
  • Qure.ai Technologies Pvt. Ltd
  • RapidAI, Inc.
  • Siemens Healthineers AG
  • Subtle Medical, Inc.
  • Viz.ai, Inc.
  • Zebra Medical Vision Ltd

Table Information

Report AttributeDetails
No. of Pages188
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.41 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned18

Related Topics

Related Reports

AI Medical Imaging Software for Acute Cerebrovascular Disease Market - Global Forecast 2026-2032 - Product Image

AI Medical Imaging Software for Acute Cerebrovascular Disease Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
AI Medical Imaging Software for Chronic Cerebrovascular Diseases Market - Global Forecast 2026-2032 - Product Image

AI Medical Imaging Software for Chronic Cerebrovascular Diseases Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Cardiac Imaging Software Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2032 - Product Image

Cardiac Imaging Software Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2032

  • Report
  • 255 Pages
  • Global
From
Medical X-Ray Equipment and Imaging Software Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Medical X-Ray Equipment and Imaging Software Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Medical X-Ray Equipment and Imaging Software Market Report 2025 - Product Image

Medical X-Ray Equipment and Imaging Software Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.